Cargando…

Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor

The objective of this study was to investigate the platelet-to-lymphocyte ratio (PLR) in patients who underwent intravesical treatment for non-muscle invasive bladder cancer (NMIBC). A total of 197 patients who underwent intravesical Bacillus Calmette-Guerin treatment after transurethral resection o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ruicheng, Li, Dengxiong, Zhang, Facai, Bai, Yunjin, Wang, Xiaoming, Han, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411071/
https://www.ncbi.nlm.nih.gov/pubmed/36034368
http://dx.doi.org/10.3389/fsurg.2022.907485
_version_ 1784775238003720192
author Wu, Ruicheng
Li, Dengxiong
Zhang, Facai
Bai, Yunjin
Wang, Xiaoming
Han, Ping
author_facet Wu, Ruicheng
Li, Dengxiong
Zhang, Facai
Bai, Yunjin
Wang, Xiaoming
Han, Ping
author_sort Wu, Ruicheng
collection PubMed
description The objective of this study was to investigate the platelet-to-lymphocyte ratio (PLR) in patients who underwent intravesical treatment for non-muscle invasive bladder cancer (NMIBC). A total of 197 patients who underwent intravesical Bacillus Calmette-Guerin treatment after transurethral resection of bladder (TURB) were included. We divided the patients into different groups according to the treatment stage before and during induction treatment as Group 1 and Group 2, and set the change value of PLR as the Group 3. The cutoff values of PLR were determined through receiver operation characteristics curves analysis. we found a significant difference in recurrence-free survival (RFS) and progression-free survival (PFS) between patients with high serum PLR and those with low serum PLR in Group 1, as well as Group 2. Cox multivariate analysis revealed that tumor number ≥3, high grade, and history of carcinoma in situ (CIS) were significant factors predicting RFS and PFS. The PLR values before and during induction therapy could be used as predictors for the progression and recurrence of NMIBC patients receiving BCG immunotherapy. the PLR values after induction therapy have a stronger predictive power.
format Online
Article
Text
id pubmed-9411071
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94110712022-08-27 Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Wu, Ruicheng Li, Dengxiong Zhang, Facai Bai, Yunjin Wang, Xiaoming Han, Ping Front Surg Surgery The objective of this study was to investigate the platelet-to-lymphocyte ratio (PLR) in patients who underwent intravesical treatment for non-muscle invasive bladder cancer (NMIBC). A total of 197 patients who underwent intravesical Bacillus Calmette-Guerin treatment after transurethral resection of bladder (TURB) were included. We divided the patients into different groups according to the treatment stage before and during induction treatment as Group 1 and Group 2, and set the change value of PLR as the Group 3. The cutoff values of PLR were determined through receiver operation characteristics curves analysis. we found a significant difference in recurrence-free survival (RFS) and progression-free survival (PFS) between patients with high serum PLR and those with low serum PLR in Group 1, as well as Group 2. Cox multivariate analysis revealed that tumor number ≥3, high grade, and history of carcinoma in situ (CIS) were significant factors predicting RFS and PFS. The PLR values before and during induction therapy could be used as predictors for the progression and recurrence of NMIBC patients receiving BCG immunotherapy. the PLR values after induction therapy have a stronger predictive power. Frontiers Media S.A. 2022-05-23 /pmc/articles/PMC9411071/ /pubmed/36034368 http://dx.doi.org/10.3389/fsurg.2022.907485 Text en Copyright © 2022 Wu, Li, Zhang, Bai, Wang and Han. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Wu, Ruicheng
Li, Dengxiong
Zhang, Facai
Bai, Yunjin
Wang, Xiaoming
Han, Ping
Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor
title Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor
title_full Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor
title_fullStr Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor
title_full_unstemmed Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor
title_short Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor
title_sort prognostic value of platelet-to-lymphocyte ratio in non-muscle invasive bladder cancer patients: intravesical bacillus calmette-guerin treatment after transurethral resection of bladder tumor
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411071/
https://www.ncbi.nlm.nih.gov/pubmed/36034368
http://dx.doi.org/10.3389/fsurg.2022.907485
work_keys_str_mv AT wuruicheng prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor
AT lidengxiong prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor
AT zhangfacai prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor
AT baiyunjin prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor
AT wangxiaoming prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor
AT hanping prognosticvalueofplatelettolymphocyteratioinnonmuscleinvasivebladdercancerpatientsintravesicalbacilluscalmetteguerintreatmentaftertransurethralresectionofbladdertumor